• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kyverna Therapeutics, Inc. - Common Stock (NQ:KYTX)

8.030 +0.160 (+2.03%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 563,175
Open 7.710
Bid (Size) 8.200 (100)
Ask (Size) 8.830 (100)
Prev. Close 7.870
Today's Range 7.622 - 8.345
52wk Range 1.780 - 13.67
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
March 26, 2026
From Kyverna Therapeutics, Inc.
Via GlobeNewswire
News headline image
Kyverna Therapeutics to Present New Data from Neuroimmunology Franchise at AAN 2026
March 05, 2026
From Kyverna Therapeutics, Inc.
Via GlobeNewswire

Performance

YTD
-8.4%
-8.4%
1 Month
+1.0%
+1.0%
3 Month
-14.6%
-14.6%
6 Month
+26.5%
+26.5%
1 Year
+221.2%
+221.2%

More News

Read More
News headline image
Kyverna Therapeutics to Participate in Upcoming March Investor Conferences
March 03, 2026
From Kyverna Therapeutics, Inc.
Via GlobeNewswire
News headline image
Kyverna Therapeutics Appoints Biotech Leaders Sravan Emany and Andrew Miller to Board of Directors
February 24, 2026
From Kyverna Therapeutics, Inc.
Via GlobeNewswire
News headline image
Kyverna Therapeutics Appoints Mayo Pujols as Chief Technology Officer
February 03, 2026
From Kyverna Therapeutics, Inc.
Via GlobeNewswire
News headline image
Kyverna Therapeutics Provides Corporate Update and Outlines 2026 Strategic Priorities at the J.P. Morgan Healthcare Conference
January 12, 2026
From Kyverna Therapeutics, Inc.
Via GlobeNewswire
News headline image
Kyverna Therapeutics to Present at the J.P. Morgan 2026 Healthcare Conference
January 05, 2026
From Kyverna Therapeutics, Inc.
Via GlobeNewswire
News headline image
On Thursday, there are stocks with unusual volume. Let's take a look. ↗
December 18, 2025
Via Chartmill
News headline image
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
December 17, 2025
Via Chartmill
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
December 17, 2025
Via Chartmill
News headline image
These stocks are gapping in today's session ↗
December 17, 2025
Via Chartmill
News headline image
Kyverna Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock
December 17, 2025
From Kyverna Therapeutics, Inc.
Via GlobeNewswire
News headline image
What's going on in today's pre-market session ↗
December 17, 2025
Via Chartmill
News headline image
Stock Market Today, Dec. 15: U.S Stocks Ease as Investors Wait for Rate Clarity ↗
December 15, 2025
Via The Motley Fool
Topics Artificial Intelligence Economy Stocks
News headline image
Kyverna Therapeutics Announces Proposed Public Offering of Common Stock
December 15, 2025
From Kyverna Therapeutics, Inc.
Via GlobeNewswire
News headline image
Which stocks are moving on Monday? ↗
December 15, 2025
Via Chartmill
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Advances Health Tech (Alongside KYTX, RADX, GLSI IMNM) With a Next-Generation Treasury Strategy
December 15, 2025
Via AB Newswire
News headline image
Monday's session: top gainers and losers ↗
December 15, 2025
Via Chartmill
News headline image
Which stocks are gapping on Monday? ↗
December 15, 2025
Via Chartmill
News headline image
KYTX Stock Just Surged 11% Today – What Is The Connection With Stiff Person Syndrome? ↗
December 15, 2025
Via Stocktwits
News headline image
Kyverna Therapeutics Announces Positive Topline Data from Registrational KYSA-8 Trial of Miv-cel (KYV-101) in Stiff Person Syndrome
December 15, 2025
From Kyverna Therapeutics, Inc.
Via GlobeNewswire
News headline image
Kyverna Therapeutics to Report Topline Results from Registrational Phase 2 KYSA-8 Trial of KYV-101 in Stiff Person Syndrome
December 14, 2025
From Kyverna Therapeutics, Inc.
Via GlobeNewswire
News headline image
Palo Alto, Vizsla Silver, NetEase And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
November 20, 2025
Via Benzinga
News headline image
Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
November 12, 2025
From Kyverna Therapeutics, Inc.
Via GlobeNewswire
News headline image
Kyverna Therapeutics to Present at the Jefferies London Healthcare Conference
November 10, 2025
From Kyverna Therapeutics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Kyverna Therapeutics, Inc. - Common Stock publicly traded?
Yes, Kyverna Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Kyverna Therapeutics, Inc. - Common Stock trade on?
Kyverna Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Kyverna Therapeutics, Inc. - Common Stock?
The ticker symbol for Kyverna Therapeutics, Inc. - Common Stock is KYTX on the Nasdaq Stock Market
What is the current price of Kyverna Therapeutics, Inc. - Common Stock?
The current price of Kyverna Therapeutics, Inc. - Common Stock is 8.030
When was Kyverna Therapeutics, Inc. - Common Stock last traded?
The last trade of Kyverna Therapeutics, Inc. - Common Stock was at 03/26/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap